5-Alpha Reductase Inhibitors Increase the Risk of Aggressive Prostate Cancer: Fact or Myth
Gerald L. Andriole, Jr., MD, challenges misconceptions about 5-ARIs in urology, focusing on their role in prostate cancer.
Read MoreSelect Page
Posted by Gerald L. Andriole, Jr., MD | Feb 2025
Gerald L. Andriole, Jr., MD, challenges misconceptions about 5-ARIs in urology, focusing on their role in prostate cancer.
Read MorePosted by Margit Fisch, MD, FEAPU, FEBU | Feb 2025
Margit Fisch, MD, FEAPU, FEBU, explores informing patients before urethroplasty, various surgical techniques, and possible complications.
Read MorePosted by Jay Simhan, MD, FACS | Feb 2025
Jay Simhan, MD, FACS, examines the challenges of penile implants in patients with refractory erectile dysfunction and Peyronie’s disease.
Read MorePosted by Katherine Amin, MD | Feb 2025
Katherine Amin, MD, updates on managing neurogenic bladder, focusing on guidelines, risk stratification, and treatment strategies.
Read MorePosted by Amy Krambeck, MD | Feb 2025
Amy E. Krambeck, MD, discusses the metabolic management of kidney stones and provides a comprehensive overview of pharmacologic treatments.
Read More